Your session is about to expire
← Back to Search
Imaging Device
Macular Involvement in Diabetic Retinopathy Evaluated With Swept-Source OCT
N/A
Waitlist Available
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights
No Placebo-Only Group
Summary
This trial uses advanced imaging tools to take detailed pictures of the tiny blood vessels in the eyes of people with diabetes. It focuses on patients with different levels of diabetic retinopathy, a common complication that can impair vision. The imaging techniques use light waves to capture detailed images, helping doctors see changes that aren't visible with regular eye exams.
Eligible Conditions
- Diabetic Retinopathy
- Diabetes
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Perfusion density
Secondary study objectives
Areas of different perfusion density
Change in perfusion density in patients with moderate or severe non proliferative diabetic retinopathy (DR) or low risk proliferative DR over the follow up of one year
Foveal avascular zone (FAZ)
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: OCTAExperimental Treatment1 Intervention
Patients with diabetes and healthy controls will be imaged with optical coherence tomography (OCT) angiography, Spectral domain OCT and ultra wide-field imaging.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Optical coherence tomography angiography
2017
N/A
~420
Find a Location
Who is running the clinical trial?
University of British ColumbiaLead Sponsor
1,472 Previous Clinical Trials
2,489,445 Total Patients Enrolled
4 Trials studying Diabetic Retinopathy
38 Patients Enrolled for Diabetic Retinopathy